Literature DB >> 26506284

The Expression of Lung Resistance Protein in Saliva: A Novel Prognostic Indicator Protein for Carcinoma of the Breast.

Nelson Wood1, Charles F Streckfus2.   

Abstract

Considering that saliva is a fluid inundated with proteins, it is possible that solubilized oncogenic proteins may be present in saliva and may be useful in differentiating between healthy and diseased individuals. As a consequence, the purpose of this study was to determine if the solubilized form of LRP was present in stimulated whole saliva and could differentiate between 16 healthy women and 16 women with confirmed Stage I breast cancer. LRP levels were determined using gel electrophoresis and Western blot technology. The results showed LRP at significantly higher concentrations among breast cancer subjects as compared to healthy women.

Entities:  

Keywords:  Breast cancer; Lung resistant protein; Saliva

Mesh:

Substances:

Year:  2015        PMID: 26506284     DOI: 10.3109/07357907.2015.1081920

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  10 in total

Review 1.  Clinical validity of saliva and novel technology for cancer detection.

Authors:  Karolina Elżbieta Kaczor-Urbanowicz; Fang Wei; Shannon Liu Rao; Jinseok Kim; Heebum Shin; Jordan Cheng; Michael Tu; David T W Wong; Yong Kim
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

2.  Salivary biomarkers for cancer diagnosis: a meta-analysis.

Authors:  Óscar Rapado-González; Cristina Martínez-Reglero; Ángel Salgado-Barreira; Bahi Takkouche; Rafael López-López; María Mercedes Suárez-Cunqueiro; Laura Muinelo-Romay
Journal:  Ann Med       Date:  2020-04-11       Impact factor: 4.709

Review 3.  Saliva Diagnostics.

Authors:  Taichiro Nonaka; David T W Wong
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2022-06-13       Impact factor: 12.400

Review 4.  Salivary biomarkers in cancer detection.

Authors:  Xiaoqian Wang; Karolina Elżbieta Kaczor-Urbanowicz; David T W Wong
Journal:  Med Oncol       Date:  2016-12-10       Impact factor: 3.064

Review 5.  Saliva-Exosomics in Cancer: Molecular Characterization of Cancer-Derived Exosomes in Saliva.

Authors:  Taichiro Nonaka; David T W Wong
Journal:  Enzymes       Date:  2017-10-09

6.  Expression of resistance gene and prognosis of chemotherapy in primary epithelial ovarian cancer.

Authors:  Fengmei Yang; Bo Gao; Wei Chen; Enfu Du; Yong Liang; Xiuxue Hu; Xiaofeng Yang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

Review 7.  Salivary Exosomes as Nanocarriers for Cancer Biomarker Delivery.

Authors:  Jordan Cheng; Taichiro Nonaka; David T W Wong
Journal:  Materials (Basel)       Date:  2019-02-21       Impact factor: 3.748

Review 8.  Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue.

Authors:  Vrinda Gote; Anantha Ram Nookala; Pradeep Kumar Bolla; Dhananjay Pal
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 9.  Salivary biomarkers in breast cancer diagnosis: A systematic review and diagnostic meta-analysis.

Authors:  Maryam Koopaie; Sajad Kolahdooz; Mahnaz Fatahzadeh; Soheila Manifar
Journal:  Cancer Med       Date:  2022-03-22       Impact factor: 4.711

Review 10.  Cancer Salivary Biomarkers for Tumours Distant to the Oral Cavity.

Authors:  Óscar Rapado-González; Blanca Majem; Laura Muinelo-Romay; Rafa López-López; María Mercedes Suarez-Cunqueiro
Journal:  Int J Mol Sci       Date:  2016-09-12       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.